遺伝子治療の精度を高める新たな回路技術(Gene circuits enable more precise control of gene therapy)

ad

2025-04-28 マサチューセッツ工科大学(MIT)

マサチューセッツ工科大学(MIT)の研究チームは、遺伝子治療の精度を高める新たな制御回路「ComMAND(Compact microRNA-mediated attenuator of noise and dosage)」を開発しました。この回路は、治療用遺伝子とその発現を抑制するマイクロRNAを同時に生成することで、遺伝子発現量を適切な範囲に保ちます。これにより、発現不足による効果の低下や、過剰発現による副作用のリスクを軽減できます。研究では、フリードライヒ運動失調症や脆弱X症候群の原因遺伝子を対象に、ヒト細胞内での発現量を約8倍に調整し、従来の50倍以上の過剰発現を抑制することに成功しました。この技術は、ウイルスベクター1つで導入可能なコンパクト設計であり、製造効率の向上や他の疾患への応用も期待されています。

<関連情報>

マイクロRNAに基づく遺伝子回路のモデル誘導設計により、多様な初代細胞への遺伝子導入カーゴの正確な投与が可能になる Model-guided design of microRNA-based gene circuits supports precise dosage of transgenic cargoes into diverse primary cells

Kasey S. Love ∙ Christopher P. Johnstone ∙ Emma L. Peterman ∙ Stephanie Gaglione ∙ Michael E. Birnbaum, ∙ Kate E. Galloway
Cell Systems  Published:April 28, 2025
DOI:https://doi.org/10.1016/j.cels.2025.101269

Graphical abstract

遺伝子治療の精度を高める新たな回路技術(Gene circuits enable more precise control of gene therapy)

Highlights

  • ComMAND constrains the expression of output proteins across delivery methods
  • ComMAND-regulated protein levels scale sublinearly with DNA dosage
  • Modeling identifies physiological limits and tuning strategies for optimizing ComMAND
  • ComMAND functions in primary cells and regulates clinically relevant genes

Summary

In a therapeutic context, supraphysiological expression of transgenes can compromise engineered phenotypes and lead to toxicity. To ensure a narrow range of transgene expression, we developed a single-transcript, microRNA-based incoherent feedforward loop called compact microRNA-mediated attenuator of noise and dosage (ComMAND). We experimentally tuned the ComMAND output profile, and we modeled the system to explore additional tuning strategies. By comparing ComMAND to two-gene implementations, we demonstrate the precise control afforded by the single-transcript architecture, particularly at low copy numbers. We show that ComMAND tightly regulates transgene expression from lentiviruses and precisely controls expression in primary human T cells, primary rat neurons, primary mouse embryonic fibroblasts, and human induced pluripotent stem cells. Finally, ComMAND effectively sets levels of the clinically relevant transgenes frataxin (FXN) and fragile X messenger ribonucleoprotein 1 (Fmr1) within a narrow window. Overall, ComMAND is a compact tool well suited to precisely specify the expression of therapeutic cargoes. A record of this paper’s transparent peer review process is included in the supplemental information.

細胞遺伝子工学
ad
ad
Follow
ad
タイトルとURLをコピーしました